Upfront fee and milestones
Novavax·Products & Services·1 segment
Breakdown
Segments
Database lock of an Existing Phase 2/3 clinical trialView metric
| Segment | Q1 '25 | Q2 '25 | Q1 '26 |
|---|---|---|---|
| Database lock of an Existing Phase 2/3 clinical trial | $500M | $500M | $500M |
| Total | $500M | $500M | $500M |